Neowise Biotechnology
PrivateLast Round
Series B
Jan 26, 2026
Total Funding Raised
$72.7M
Company Overview
Neowise Biotechnology is a biotechnology company that develops TCR-T cell therapies for solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Data as a Service
AI Layer
Application
Keywords
TCR-T cell therapyTCR-Tsolid tumor treatmentcell therapyTCR discovery platformAI drug discoveryimmunotherapyTCR librarybioinformaticsclinical-stage biotechbiotech licensingKRAS G12VPRAME
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neowise Biotechnology Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Neowise Biotechnology Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 26, 2026 | ||||
| Series A Extension | Mar 15, 2023 | ||||
| Series A | Oct 14, 2021 | ||||
| Angel | Oct 1, 2020 |
Neowise Biotechnology Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Baidu Ventures | Angel |
| Oriza Holdings | Series B |
| TF Capital | Series A |
| 健壹资本 | Series A |
| Suzhou Angel Investment Guidance Fund | Series B |
| Marathon Venture Partners | Series A Extension |
| Delian Capital | Series B |
Neowise Biotechnology Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Neowise Biotechnology's valuation, stock price, and market status.